Donald Trump tariffs trigger sector churn with more losers than winners

Global markets reeled from the sweeping tariffs imposed by US President Donald Trump, but India's benchmark indices emerged relatively unscathed on Thursday, dipping by a modest 0.4 per cent. However, a closer examination of stock and sectoral performance reveals a more nuanced impact, with the tariffs creating a mix of winners and losers.

 

Pharmaceuticals

 

The Nifty Pharma index surged 2.25 per cent after the pharmaceutical sector was unexpectedly spared from reciprocal tariffs, at least for now. Companies with significant US exposure, such as Ipca Laboratories, Lupin, Natco Pharma, Sun Pharmaceutical, and Cipla, saw their shares rise between 3 per cent